Tetherex Pharmaceuticals

$4.5M revenue • 25 employees • 840 Research Pkwy, Oklahoma City, OK, 73104, United States

Last Updated Jan 28, 2026

Company Overview

Company Name

Tetherex Pharmaceuticals

Address

840 Research Pkwy, Oklahoma City, OK, 73104, United States

Approx. Annual Revenue

$4.5M

Employees

25

Established

2014

About Tetherex Pharmaceuticals

Tetherex Pharmaceuticals is a clinical-stage drug development company based in the United States. Founded in 2014 as a spin-off of Selexys Pharmaceuticals, Tetherex is committed to advancing the understanding of inflammation and developing novel treatments for inflammatory diseases, infectious diseases, and cancer. The company's lead program focuses on a functionally blocking anti-PSGL-1 antibody for the treatment of asthma and chronic obstructive pulmonary disease.

Business Profile

Read from the Tetherex Pharmaceuticals website on Oct 14, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
6/10 · Thin content, no contact details; No services or patient information

Biotech & Life Sciences Companies near Oklahoma City, OK

Browse all Biotech & Life Sciences companies →

Frequently Asked Questions about Tetherex Pharmaceuticals

Categories

Technologies Used

Key Decision Makers

Amy Ascher Associate Director, Clinical Operations
LinkedIn